Allosteric inhibition of HIV-1 integrase activity. 2013

Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, 450 Brookline Avenue, CLS-1010, Boston, MA 02215, USA. alan_engelman@dfci.harvard.edu

HIV-1 integrase is an important therapeutic target in the fight against HIV/AIDS. Integrase strand transfer inhibitors (INSTIs), which target the enzyme active site, have witnessed clinical success over the past 5 years, but the generation of drug resistance poses challenges to INSTI-based therapies moving forward. Integrase is a dynamic protein, and its ordered multimerization is critical to enzyme activity. The integrase tetramer, bound to viral DNA, interacts with host LEDGF/p75 protein to tether integration to active genes. Allosteric integrase inhibitors (ALLINIs) that compete with LEDGF/p75 for binding to integrase disrupt integrase assembly with viral DNA and allosterically inhibit enzyme function. ALLINIs display steep dose response curves and synergize with INSTIs ex vivo, highlighting this novel inhibitor class for clinical development.

UI MeSH Term Description Entries
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019427 HIV Integrase Enzyme of the HUMAN IMMUNODEFICIENCY VIRUS that is required to integrate viral DNA into cellular DNA in the nucleus of a host cell. HIV integrase is a DNA nucleotidyltransferase encoded by the pol gene. HIV Integration Protein,p31 Integrase Protein, HIV,p31 Integrase Protein, Human Immunodeficiency Virus,p31 pol Gene Product, HIV,p31 pol Gene Product, Human Immunodeficiency Virus,Integrase, HIV,Integration Protein, HIV
D019428 HIV Integrase Inhibitors Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA. Integrase Inhibitors, HIV,Inhibitors, HIV Integrase
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
February 2011, ChemMedChem,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
October 2016, Bioorganic & medicinal chemistry letters,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
July 2022, Viruses,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
November 2013, Expert reviews in molecular medicine,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
May 2008, Chemical & pharmaceutical bulletin,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
December 2022, Viruses,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
May 2019, eLife,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
May 2006, Chemical & pharmaceutical bulletin,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
December 2002, Journal of medicinal chemistry,
Alan Engelman, and Jacques J Kessl, and Mamuka Kvaratskhelia
December 2002, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!